STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
AZRX AZURRX BIOPHARMA INCORPORATED StockScouter® Report
1
StockScouter® Score
AZURRX BIOPHARMA INCORPORATED, a company in the sector, is expected to underperform the market over the next six months with higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
Concerns
- Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
- Moving average analysis for AZRX suggests weak price movement over the medium term. Negative
- Short-term relative price momentum exhibits meaningful weakness. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that stocks will be , stocks will be , and stocks will be .
Expected Risk/Return
Core Model Grades
F
N/A
N/A
D